Next Article in Journal
Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy
Previous Article in Journal
Transscleral Delivery of Dexamethasone-Loaded Microparticles Using a Dissolving Microneedle Array
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 15
Issue 6
10.3390/pharmaceutics15061623
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Retraction of Pharmaceutics 2021, 13(3), 330.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

by
Shiwei Zhou
1,2,3,†,
Obinna N. Obianom
2,†,
Jiangsheng Huang
3,
Dong Guo
2,
Hong Yang
2,
Qing Li
1,* and
Yan Shu
1,2,*
1
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
3
Department of Thyroid Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China
*
Authors to whom correspondence should be addressed.
†
These authors contribute equally to the work.
Pharmaceutics 2023, 15(6), 1623; https://doi.org/10.3390/pharmaceutics15061623
Submission received: 6 December 2022 / Accepted: 7 February 2023 / Published: 30 May 2023
Versions Notes
The authors and the journal retract the article, ‘Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation’ [1].
Following publication, the authors contacted the journal’s Editorial Office regarding two sets of mistakenly duplicated figures: Figure 3E is a copy of Figure 3D, and the loading control of Figure 4D is a copy of Figure 5A’s loading control.
Adhering to the journal complaints procedure, an investigation was conducted. The authors were unable to locate the original gel image of Figure 4D’s loading control data. The authors, the Editorial Board, and the Editor-in-Chief have agreed that the findings are no longer reliable, and the article was therefore retracted.
This retraction was approved by the Editor-in-Chief of the journal Pharmaceutics.
The authors agreed to this retraction.

Reference

  1. Zhou, S.; Obianom, O.N.; Huang, J.; Guo, D.; Yang, H.; Li, Q.; Shu, Y. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhou, S.; Obianom, O.N.; Huang, J.; Guo, D.; Yang, H.; Li, Q.; Shu, Y. RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330. Pharmaceutics 2023, 15, 1623. https://doi.org/10.3390/pharmaceutics15061623

AMA Style

Zhou S, Obianom ON, Huang J, Guo D, Yang H, Li Q, Shu Y. RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330. Pharmaceutics. 2023; 15(6):1623. https://doi.org/10.3390/pharmaceutics15061623

Chicago/Turabian Style

Zhou, Shiwei, Obinna N. Obianom, Jiangsheng Huang, Dong Guo, Hong Yang, Qing Li, and Yan Shu. 2023. "RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330" Pharmaceutics 15, no. 6: 1623. https://doi.org/10.3390/pharmaceutics15061623

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop